Skip to main content
. 2022 Jul 13;15:3733–3749. doi: 10.2147/IDR.S371131

Figure 5.

Figure 5

Forest plot for the safety of randomized controlled trials with rifaximin-containing regimens. (A) Rifaximin-containing vs controlled group (ITTA). (B) Rifaximin-containing vs controlled group (PPA). (C) Rifaximin-containing triple vs standard triple regimen (ITTA). (D) Rifaximin-containing triple vs standard triple regimen, (PPA).

Abbreviations: ITTA, intention-to-treat analysis; PPA, per-protocol analysis; RR, risk ratio.